# A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer

> **NCT03514836** · PHASE1,PHASE2 · TERMINATED · sponsor: **SOTIO a.s.** · enrollment: 5 (actual)

## Conditions studied

- Castration-resistant Prostate Cancer

## Interventions

- **BIOLOGICAL:** DCVac/PCa
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT03514836
- **Lead sponsor:** SOTIO a.s.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-23
- **Primary completion:** 2021-01-25
- **Final completion:** 2021-01-25
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** insufficient accrual
- **Last updated:** 2021-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03514836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03514836, "A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03514836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*